evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's Nordisk, GLP-1s, Alzheimer's: Readout Newsletter Novo Nordisk scores court win

J., Ma, H., Xu, W., Lv, R., Li, X., Villen, J., Gygi, S

Glow within your own skin

One placebo-controlled study examined the effect of lipoic acid on the visual capability of 80 participants of whom 12 had type 1 diabetes, 48 had type 2 diabetes, and 20 were diabetes-free

It provides antioxidant support and may aid in achieving a radiantlooking complexion when used under professional supervision

WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy